Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics

Overview of attention for article published in The AAPS Journal, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 1,419)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 15 X users

patent: 8 patents

Readers on

mendeley: 214 Mendeley

So far, Altmetric has seen 21 X posts from 15 X users, with an upper bound of 24,901 followers.

@Rinkils1 @_whatzmyname @PeterSweden7 https://t.co/6GZGN25IRN

@ovierocks1 @JinyD1950 @DrAseemMalhotra @MrAhmadKMalik @ABridgen https://t.co/6GZGN25IRN

@Rinkils1 @_whatzmyname @PeterSweden7 “achieving specific targeting of gene therapy to the location of interest without off-target effects is a primary challenge for clinical therapeutics.” https://t.co/6GZGN25IRN

@ovierocks1 @JinyD1950 @DrAseemMalhotra @MrAhmadKMalik @ABridgen https://t.co/6GZGN25IRN

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 17 additional X posts.